AXITINIB

axitinib 5 mg tablet, 28

AXITINIB (10540R)

axitinib 5 mg tablet, 28
10540R
Body System:
Manner of administration:Oral
General Schedule
Authority Required

Restriction

Indication: Stage IV clear cell variant renal cell carcinoma (RCC)
Treatment phase: Initial treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 2 Max qty units: 56 # of repeats: 2 DPMQ: $4,711.54 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Inlyta